FEMY
Price
$4.08
Change
-$0.01 (-0.25%)
Updated
Jun 23, 03:46 PM (EDT)
Capitalization
12.32M
50 days until earnings call
Intraday BUY SELL Signals
OM
Price
$4.76
Change
-$0.12 (-2.46%)
Updated
Jun 23, 04:09 PM (EDT)
Capitalization
90.65M
43 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FEMY vs OM

FEMY vs OM Comparison Chart in %
View a ticker or compare two or three
VS
FEMY vs. OM commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEMY is a Hold and OM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (FEMY: $4.08 vs. OM: $4.89)
Brand notoriety: FEMY and OM are both not notable
FEMY represents the Pharmaceuticals: Other, while OM is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: FEMY: 60% vs. OM: 114%
Market capitalization -- FEMY: $12.32M vs. OM: $90.65M
FEMY [@Pharmaceuticals: Other] is valued at $12.32M. OM’s [@Medical/Nursing Services] market capitalization is $90.65M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $142.71B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $152.98B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.5B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FEMY’s FA Score shows that 0 FA rating(s) are green whileOM’s FA Score has 1 green FA rating(s).

  • FEMY’s FA Score: 0 green, 5 red.
  • OM’s FA Score: 1 green, 4 red.
According to our system of comparison, OM is a better buy in the long-term than FEMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FEMY’s TA Score shows that 4 TA indicator(s) are bullish while OM’s TA Score has 6 bullish TA indicator(s).

  • FEMY’s TA Score: 4 bullish, 4 bearish.
  • OM’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, OM is a better buy in the short-term than FEMY.

Price Growth

FEMY (@Pharmaceuticals: Other) experienced а +2.51% price change this week, while OM (@Medical/Nursing Services) price change was +13.46% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.31%. For the same industry, the average monthly price growth was -0.98%, and the average quarterly price growth was -14.76%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.22%. For the same industry, the average monthly price growth was -3.84%, and the average quarterly price growth was -16.30%.

Reported Earning Dates

FEMY is expected to report earnings on Aug 12, 2026.

OM is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.31% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.22% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OM($90.6M) has a higher market cap than FEMY($12.3M). OM YTD gains are higher at: 31.806 vs. FEMY (-64.596). FEMY has higher annual earnings (EBITDA): -9.44M vs. OM (-56.43M). FEMY has less debt than OM: FEMY (4.73M) vs OM (102M). OM has higher revenues than FEMY: OM (118M) vs FEMY (2.38M).
FEMYOMFEMY / OM
Capitalization12.3M90.6M14%
EBITDA-9.44M-56.43M17%
Gain YTD-64.59631.806-203%
P/E RatioN/AN/A-
Revenue2.38M118M2%
Total CashN/A157M-
Total Debt4.73M102M5%
TECHNICAL ANALYSIS
Technical Analysis
FEMYOM
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 26 days ago
82%
Bullish Trend 22 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 13 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
FEMY
Daily Signal:
Gain/Loss:
OM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EAEMX19.42N/A
N/A
Parametric Emerging Markets A
AWPYX23.90N/A
N/A
AB Sustainable Intl Thematic Advisor
FCDTX46.23N/A
N/A
Fidelity Advisor Stock Selector Sm Cp M
TANDX30.45N/A
N/A
Tandem Fund
BEQAX38.21N/A
N/A
American Century Disciplined Core Eq A

FEMY and

Correlation & Price change

A.I.dvisor tells us that FEMY and OFIX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FEMY and OFIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FEMY
1D Price
Change %
FEMY100%
+0.99%
OFIX - FEMY
30%
Poorly correlated
-5.19%
CSTL - FEMY
30%
Poorly correlated
+0.38%
LUCD - FEMY
30%
Poorly correlated
-4.63%
OM - FEMY
29%
Poorly correlated
-3.17%
GH - FEMY
29%
Poorly correlated
-2.24%
More

OM and

Correlation & Price change

A.I.dvisor indicates that over the last year, OM has been loosely correlated with COO. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OM jumps, then COO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OM
1D Price
Change %
OM100%
-3.17%
COO - OM
34%
Loosely correlated
-0.74%
CVRX - OM
33%
Loosely correlated
-1.82%
RMD - OM
33%
Loosely correlated
-0.10%
GH - OM
32%
Poorly correlated
-2.24%
KIDS - OM
31%
Poorly correlated
-3.66%
More